Keli Xu

4.0k total citations · 1 hit paper
52 papers, 3.0k citations indexed

About

Keli Xu is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Keli Xu has authored 52 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 21 papers in Oncology and 11 papers in Surgery. Recurrent topics in Keli Xu's work include Cancer Cells and Metastasis (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Developmental Biology and Gene Regulation (6 papers). Keli Xu is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Developmental Biology and Gene Regulation (6 papers). Keli Xu collaborates with scholars based in United States, China and Canada. Keli Xu's co-authors include Richard S. Lewis, Ricardo E. Dolmetsch, Nektarios Tavernarakis, Monica Driscoll, Sean E. Egan, Popi Syntichaki, Shubing Zhang, Wen-Cheng Chung, Nadeem Moghal and Barbara Baird and has published in prestigious journals such as Nature, Neuron and The Journal of Cell Biology.

In The Last Decade

Keli Xu

44 papers receiving 3.0k citations

Hit Papers

Calcium oscillations increase the efficiency and specific... 1998 2026 2007 2016 1998 500 1000 1.5k

Peers

Keli Xu
Xin‐Yun Huang United States
Xiaowei Lu United States
Joshua S. Kaminker United States
Guangwei Du United States
Thomas M. Wilkie United States
Dale W. Hailey United States
Mike J. Mason United States
Xin‐Yun Huang United States
Keli Xu
Citations per year, relative to Keli Xu Keli Xu (= 1×) peers Xin‐Yun Huang

Countries citing papers authored by Keli Xu

Since Specialization
Citations

This map shows the geographic impact of Keli Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keli Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keli Xu more than expected).

Fields of papers citing papers by Keli Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keli Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keli Xu. The network helps show where Keli Xu may publish in the future.

Co-authorship network of co-authors of Keli Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Keli Xu. A scholar is included among the top collaborators of Keli Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keli Xu. Keli Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Xu, Keli, et al.. (2024). CRISPR-Cpf1 system and its applications in animal genome editing. Molecular Genetics and Genomics. 299(1). 75–75. 1 indexed citations
4.
Hurwitz, Eric, Parash Parajuli, Céline Prunier, et al.. (2023). Antagonism between Prdm16 and Smad4 specifies the trajectory and progression of pancreatic cancer. The Journal of Cell Biology. 222(4). 10 indexed citations
5.
Chung, Wen-Cheng & Keli Xu. (2023). Notch signaling pathway in pancreatic tumorigenesis. Advances in cancer research. 159. 1–36. 7 indexed citations
6.
Huang, Zhi, Ameya S. Champhekar, Deniz A. Uçar, et al.. (2022). Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses. Frontiers in Immunology. 13. 987298–987298. 7 indexed citations
7.
Chung, Wen-Cheng, Lavanya Challagundla, Yunyun Zhou, et al.. (2020). Loss of Jag1 cooperates with oncogenic Kras to induce pancreatic cystic neoplasms. Life Science Alliance. 4(2). e201900503–e201900503. 6 indexed citations
8.
Parajuli, Parash, et al.. (2020). Pancreatic cancer triggers diabetes through TGF-β–mediated selective depletion of islet β-cells. Life Science Alliance. 3(6). e201900573–e201900573. 20 indexed citations
9.
Ling, Hong, Yaozhong Liu, Hao Yang, et al.. (2020). <p>Targeting PIK3CG in Combination with Paclitaxel as a Potential Therapeutic Regimen in Claudin-Low Breast Cancer</p>. Cancer Management and Research. Volume 12. 2641–2651. 15 indexed citations
10.
Chung, Wen-Cheng, et al.. (2019). Downregulation of Notch Signaling in Kras-Induced Gastric Metaplasia. Neoplasia. 21(8). 810–821. 3 indexed citations
11.
Garg, Ankur, et al.. (2018). FGF-induced Pea3 transcription factors program the genetic landscape for cell fate determination. PLoS Genetics. 14(9). e1007660–e1007660. 23 indexed citations
12.
Zhang, Shubing, Wen-Cheng Chung, Guanming Wu, et al.. (2015). Manic Fringe Promotes a Claudin-Low Breast Cancer Phenotype through Notch-Mediated PIK3CG Induction. Cancer Research. 75(10). 1936–1943. 57 indexed citations
13.
Xu, Keli. (2015). Breast cancer regulated by fringe. Oncoscience. 2(10). 829–830. 1 indexed citations
14.
Zhang, Shubing, Wen-Cheng Chung, Guanming Wu, Sean E. Egan, & Keli Xu. (2014). Tumor-Suppressive Activity of Lunatic Fringe in Prostate through Differential Modulation of Notch Receptor Activation. Neoplasia. 16(2). 158–167. 30 indexed citations
15.
Zhang, Shubing, Wen-Cheng Chung, Lucio Miele, & Keli Xu. (2014). Targeting Met and Notch in theLfng-deficient,Met-amplified triple-negative breast cancer. Cancer Biology & Therapy. 15(5). 633–642. 28 indexed citations
16.
Adams, Jessica R., Keli Xu, Jeff C. Liu, et al.. (2011). Cooperation between Pik3ca and p53 Mutations in Mouse Mammary Tumor Formation. Cancer Research. 71(7). 2706–2717. 106 indexed citations
17.
Suliman, Sara, Joanne B.L. Tan, Keli Xu, et al.. (2011). Notch3 Is Dispensable for Thymocyte β-Selection and Notch1-Induced T Cell Leukemogenesis. PLoS ONE. 6(9). e24937–e24937. 17 indexed citations
18.
Syntichaki, Popi, Keli Xu, Monica Driscoll, & Nektarios Tavernarakis. (2002). Specific aspartyl and calpain proteases are required for neurodegeneration in C. elegans. Nature. 419(6910). 939–944. 249 indexed citations
19.
Xu, Keli, Nektarios Tavernarakis, & Monica Driscoll. (2001). Necrotic Cell Death in C. elegans Requires the Function of Calreticulin and Regulators of Ca2+ Release from the Endoplasmic Reticulum. Neuron. 31(6). 957–971. 223 indexed citations
20.
Xu, Keli, Byron Goldstein, David Holowka, & Barbara Baird. (1998). Kinetics of Multivalent Antigen DNP-BSA Binding to IgE-FcεRI in Relationship to the Stimulated Tyrosine Phosphorylation of FcεRI. The Journal of Immunology. 160(7). 3225–3235. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026